786P A phase II trial of paclitaxel, ifosfamid and cisplatin in patients with poor-prognosis disseminated non-seminomatous germ cell tumors with unfavorable serum tumor marker decline after first cycle of chemotherapy
| Autor: | Mego, M., Svetlovska, D., Rejlekova, K., Miskovska, V., De Angelis, V., Kalavska, K., Obertova, J., Palacka, P., Sycova-Mila, Z., Chovanec, M., Mardiak, J. |
|---|---|
| Zdroj: | In Annals of Oncology September 2020 31 Supplement 4:S600-S600 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|